Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences filings provide 5 years of Revenue readings, the most recent being $2419.0 for Q4 2025.

  • On a quarterly basis, Revenue changed N/A to $2419.0 in Q4 2025 year-over-year; TTM through Jan 2026 was $8669.0, a 53.39% decrease, with the full-year FY2025 number at $4350.0, down 76.61% from a year prior.
  • Revenue hit $2419.0 in Q4 2025 for HeartSciences, up from $1900.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $14700.0 in Q1 2024 to a low of $1900.0 in Q3 2025.
  • Median Revenue over the past 5 years was $3550.0 (2022), compared with a mean of $4679.2.
  • Biggest five-year swings in Revenue: plummeted 57.24% in 2022 and later skyrocketed 653.85% in 2024.
  • HeartSciences' Revenue stood at $7484.0 in 2021, then plummeted by 57.24% to $3200.0 in 2022, then increased by 21.88% to $3900.0 in 2023, then surged by 276.92% to $14700.0 in 2024, then tumbled by 83.54% to $2419.0 in 2025.
  • The last three reported values for Revenue were $2419.0 (Q4 2025), $1900.0 (Q3 2025), and $4350.0 (Q2 2025) per Business Quant data.